IP Library › Granted Patent US 8,742,126
Granted Patent B2
US 8,742,126 · App. 13/748,901 · Granted Jun 3, 2014

Apoptosis signal-regulating kinase inhibitor

Inventor: Gregory Notte (San Mateo, CA)
Assignee: Gilead Sciences, Inc.
C07D213/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,742,126
App. No.
13/748,901
Granted
Jun 3, 2014
Kind
B2
Abstract

The present invention relates to a compound of formula (I): The compound has apoptosis signal-regulating kinase (“ASK1”) inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis.

Claims (3)

1. A compound of formula (I)

or a pharmaceutically acceptable salt thereof.

2. A pharmaceutically composition comprising a compound of claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2013
From: NOTTE, GREGORY
To: GILEAD SCIENCES, INC.
Reel/Frame 030033/0805 →
Continuity (2)
Provisional Application 61591710 · Jan 27, 2012
Related Publication 20130197037A1 · Aug 1, 2013